Sumit chrono
8 months ago
Stem cell therapy for ARMD in UAE: what pigment-cell research has shown so far
ARMD is one of the better-studied targets for cell therapy, mainly because the cells at the heart of the damage are well defined.
Why ARMD attracts cell research
The macula depends on a thin layer of retinal pigment epithelium to feed and clean the light-sensing cells above it. In advanced ARMD this layer fails. Researchers have therefore tried to grow replacement pigment cells from stem cells and place them under the retina, sometimes on a thin supporting sheet.
Early trials in dry and wet disease reported that the cells could survive in some eyes and that the procedure could be performed with acceptable safety.
What has not been shown
Trials so far are small, and many measure safety instead of visual benefit. Outcomes vary, and some patients developed scarring or inflammation. Large studies comparing treated and untreated eyes are still needed before any therapy can be called established.
Be cautious about any clinic that presents these experiments as routine care.
How to read a claim
Look for the trial registry number, the stage of ARMD included, the measure used for success and the length of follow-up. Real data come with numbers, dates and limitations.
Details to verify
- Phase of the studyPhase 1 tests safety only.
- Eyes treatedOne eye or both?
- Comparison groupNeeded to judge benefit.
- Follow-up periodAt least a year is useful.
- Reported side effectsThey should be listed openly.
Related approaches
Anti-VEGF
Established for wet ARMD.
Complement inhibitors
Approved in some countries for atrophy.
Cell patches
Experimental.
Gene approaches
Early research.
Before exploring research
Update scans
Recent OCT and autofluorescence.
Know your stage
Dry, wet or atrophic.
Review current treatment
Do not stop injections.
List other conditions
Heart and diabetes matter.
Common questions
- Is it available routinely?No.
- Could it replace injections?Not at present.
- Is surgery required?Yes, in most designs.
- How can I share files?Use the report page.
Our Medical Experts – Trusted Specialists
Eye Stem Cell Center brings together pioneers in stem cell biotechnology and highly experienced ophthalmologists to provide advanced regenerative eye care with compassion and precision.
Dr. Pallavi
Senior Consultant | Ophthalmologist & Eye Surgeon22+ Years ExperienceDr. Pallavi is renowned for her expertise in cataract and corneal surgeries. With thousands of successful procedures, she combines surgical precision with a patient‑first approach.
Get ConsultationDr. Robin
Consultant Ophthalmologist & Eye Surgeon | MD, DO16+ Years ExperienceDr. Robin specializes in advanced cataract surgery, refractive procedures, and keratoconus treatment. His clinical excellence ensures patients receive world‑class eye care.
Get ConsultationDr. Pawan
Associate Professor | Vitreo-Retina Surgeon10+ Years ExperienceDr. Pawan is an expert in retinal disorders, diabetic retinopathy, and advanced retina procedures. His patient‑focused approach ensures precise treatment and long‑term vision care.
Get ConsultationFrequently asked questions
Are stem cell treatments for ARMD approved?
Not as standard care. They remain research-stage.
What cells are used?
Mostly retinal pigment epithelial cells derived from stem cells.
Does it replace anti-VEGF injections?
No. Injections stay the standard for wet disease.
Is surgery involved?
In most studies, yes, to place cells under the retina.
Who is eligible for trials?
Usually people with advanced, defined disease and stable findings.
What are the risks?
Bleeding, scarring and immune reaction are possible.
